Novynette (Desogestrel, Ethinylestradiol)

Desogestrel, the active ingredient in Novynette, is a progestin presented as a combined oral contraceptive for oral use. It prevents ovulation and stabilizes the uterine lining to provide reliable birth control for women of reproductive age. GNH USA supplies Novynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novynette combines desogestrel and ethinylestradiol to regulate hormonal pathways that prevent pregnancy.

- Contraception: Provides reliable, reversible prevention of pregnancy in women of childbearing age. - Menstrual cycle regulation: Helps achieve more predictable menstrual bleeding patterns. - Acne management: Reduces androgen‑driven skin lesions in women when prescribed for this purpose. - Endometriosis symptom relief: Alleviates pain associated with endometrial tissue outside the uterus. - Hormone replacement therapy adjunct: Used off‑label as part of hormone therapy regimens under specialist supervision. - Polycystic ovary syndrome (PCOS) support: Assists in cycle regulation and androgen reduction when indicated.

Novynette may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: Mild to moderate stomach upset. - Headache: Tension‑type or migraine‑like pain. - Breast tenderness: Temporary swelling or discomfort. - Weight gain: Slight increase in body weight, often fluid‑related. - Mood changes: Irritability or mild depressive symptoms. - Spotting between periods: Light bleeding outside scheduled menses.

Serious or Rare Side Effects: - Venous thromboembolism: Blood clot formation in deep veins. - Pulmonary embolism: Clot migration to lung arteries. - Stroke: Cerebrovascular accident due to clot or hemorrhage. - Myocardial infarction: Heart attack risk, especially in smokers. - Severe allergic reaction: Anaphylaxis with rash, swelling, or breathing difficulty. - Liver dysfunction: Jaundice or abnormal liver enzyme levels.

Before prescribing Novynette, clinicians should evaluate individual risk factors and counsel patients on safe use.

- Smoking status: Avoid use in women over 35 who smoke due to increased thrombotic risk. - Cardiovascular history: Assess for hypertension, heart disease, or stroke history. - Migraine with aura: Contraindicated in patients experiencing aura‑type migraines. - Liver disease: Use with caution in hepatic impairment. - Pregnancy intention: Advise discontinuation if pregnancy is desired. - Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Novynette can interact with several medicines that affect hormone metabolism or clotting pathways.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole): Increase estrogen levels, raising clot risk. - Antiretroviral drugs (e.g., ritonavir): Decrease contraceptive effectiveness. - Enzyme inducers (e.g., rifampicin): Lower hormone concentrations, reducing efficacy.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs): May increase bleeding tendency. - Anticonvulsants (phenytoin, carbamazepine): Potentially reduce hormone levels. - Herbal supplements (St. St                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ...